Literature DB >> 8811672

Cortical plaques visualised by fluid-attenuated inversion recovery imaging in relapsing multiple sclerosis.

M D Boggild1, R Williams, N Haq, C P Hawkins.   

Abstract

Fluid-attenuated inversion recovery (FLAIR) imaging with prolonged inversion times allows generation of highly T2-weighted images of the brain with suppression of cerebrospinal fluid signal. Such sequences result in high lesion contrast and allow visualisation of abnormalities not seen with conventional T2-weighted spin-echo sequences. We used FLAIR sequences, proton density (PD) and standard T2-weighted images to examine lesion number and distribution in ten patients with clinically definite relapsing multiple sclerosis (MS). We also studied the extent and distribution of blood-brain-barrier breakdown by gadolinium-enhanced T1-weighted images. FLAIR sequences proved feasible both in terms of acquisition time and image quality using a 0.5 T imager. FLAIR imaging allowed identification of 45% more high-signal lesions than T2-weighted or PD images in the 10 patients. In particular, 60% more lesions within the cortex and at the grey-white interface were identified. Cortical lesions, none of which enhanced following gadolinium-DTPA injection, were present in seven of the ten patients studied. Of all lesions identified, 8% were cortical. FLAIR sequences are more sensitive to cortical and subcortical lesions in patients with active demyelination.

Entities:  

Mesh:

Year:  1996        PMID: 8811672     DOI: 10.1007/bf02278111

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

2.  Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence.

Authors:  J N Rydberg; C A Hammond; R C Grimm; B J Erickson; C R Jack; J Huston; S J Riederer
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

Review 3.  The immunology of multiple sclerosis: new intricacies and new insights.

Authors:  R M Ransohoff; V Tuohy; P Lehmann
Journal:  Curr Opin Neurol       Date:  1994-06       Impact factor: 5.710

4.  Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.

Authors:  A J Thompson; A G Kermode; D G MacManus; B E Kendall; D P Kingsley; I F Moseley; W I McDonald
Journal:  BMJ       Date:  1990-03-10

5.  Multiple sclerosis: gadolinium enhancement in MR imaging.

Authors:  R I Grossman; F Gonzalez-Scarano; S W Atlas; S Galetta; D H Silberberg
Journal:  Radiology       Date:  1986-12       Impact factor: 11.105

6.  Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis.

Authors:  D Katz; J K Taubenberger; B Cannella; D E McFarlin; C S Raine; H F McFarland
Journal:  Ann Neurol       Date:  1993-11       Impact factor: 10.422

7.  Magnetic resonance imaging of spinal cord in multiple sclerosis by fluid-attenuated inversion recovery.

Authors:  D J Thomas; J M Pennock; J V Hajnal; I R Young; G M Bydder; R E Steiner
Journal:  Lancet       Date:  1993-03-06       Impact factor: 79.321

8.  The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.

Authors:  I E Ormerod; D H Miller; W I McDonald; E P du Boulay; P Rudge; B E Kendall; I F Moseley; G Johnson; P S Tofts; A M Halliday
Journal:  Brain       Date:  1987-12       Impact factor: 13.501

9.  Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers.

Authors:  C P Hawkins; P M Munro; F MacKenzie; J Kesselring; P S Tofts; E P du Boulay; D N Landon; W I McDonald
Journal:  Brain       Date:  1990-04       Impact factor: 13.501

10.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.

Authors:  D H Miller; P Rudge; G Johnson; B E Kendall; D G Macmanus; I F Moseley; D Barnes; W I McDonald
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

View more
  7 in total

1.  In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis.

Authors:  F Bagnato; J A Butman; S Gupta; M Calabrese; L Pezawas; J M Ohayon; F Tovar-Moll; M Riva; M M Cao; S L Talagala; H F McFarland
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

2.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Authors:  Jeroen J G Geurts; Lars Bö; Petra J W Pouwels; Jonas A Castelijns; Chris H Polman; Frederik Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

Review 3.  Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.

Authors:  Brendan J Kelley; Moses Rodriguez
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

4.  Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images.

Authors:  D M Moriarty; A J Blackshaw; P R Talbot; H L Griffiths; J S Snowden; V F Hillier; S Capener; R D Laitt; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

5.  Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: observations from a post-mortem 3 Tesla imaging study.

Authors:  Francesca Bagnato; Bing Yao; Fredric Cantor; Hellmut Merkle; Ellen Condon; Marcela Montequin; Sandra Moore; Martha Quezado; Deborah Tkaczyk; Henry McFarland
Journal:  J Neurol Sci       Date:  2009-04-23       Impact factor: 3.181

6.  Cognitive presentation of multiple sclerosis: evidence for a cortical variant.

Authors:  M Zarei; S Chandran; A Compston; J Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

Review 7.  Gray matter imaging in multiple sclerosis: what have we learned?

Authors:  Hanneke E Hulst; Jeroen J G Geurts
Journal:  BMC Neurol       Date:  2011-12-12       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.